The combined effects of cardiometabolic index and high sensitivity C-reactive protein on cardiometabolic multimorbidity risk: a prospective analysis based on CHARLS - PubMed
4 hours ago
- #Inflammation
- #Cardiometabolic Health
- #Multimorbidity
- Study examines combined effects of cardiometabolic index (CMI) and high sensitivity C-reactive protein (hs-CRP) on cardiometabolic multimorbidity risk.
- Prospective analysis based on the China Health and Retirement Longitudinal Study (CHARLS).
- Ethical approval obtained from Peking University’s Ethics Review Committee with informed consent from participants.
- No competing interests declared by the authors.
- References include studies on interventions for multimorbidity, obesity's role in cardiometabolic multimorbidity, and associations between multimorbidity and mortality or cognitive function.